Literature DB >> 29209368

Corrigendum to "Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort".

Nicole Yurgin1, Sally Wade2, Sacha Satram-Hoang3, David Macarios1, Marc Hochberg4.   

Abstract

[This corrects the article DOI: 10.1155/2013/715025.].

Entities:  

Year:  2017        PMID: 29209368      PMCID: PMC5676447          DOI: 10.1155/2017/4827469

Source DB:  PubMed          Journal:  Int J Endocrinol        ISSN: 1687-8337            Impact factor:   3.257


In the article titled “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort” [1], there was an error regarding the FRAX® tool, which should be clarified as follows: The article notes “The WHO fracture risk assessment tool (FRAX) is a computer-based algorithm that assesses fracture probability of men and women [1].” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
  2 in total

1.  Clarifying WHO's position on the FRAX® tool for fracture prediction.

Authors:  Nathan Ford; Susan L Norris; Suzanne R Hill
Journal:  Bull World Health Organ       Date:  2016-12-01       Impact factor: 9.408

2.  Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort.

Authors:  Nicole Yurgin; Sally Wade; Sacha Satram-Hoang; David Macarios; Marc Hochberg
Journal:  Int J Endocrinol       Date:  2013-03-31       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.